These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 1655387)

  • 1. Nongenomic actions of 1,25-dihydroxyvitamin D3 in rat osteosarcoma cells: structure-function studies using ligand analogs.
    Farach-Carson MC; Sergeev I; Norman AW
    Endocrinology; 1991 Oct; 129(4):1876-84. PubMed ID: 1655387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Target gene activation by 1,25-dihydroxyvitamin D3 in osteosarcoma cells is independent of calcium influx.
    Khoury R; Ridall AL; Norman AW; Farach-Carson MC
    Endocrinology; 1994 Dec; 135(6):2446-53. PubMed ID: 7988430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,25-Dihydroxyvitamin D3 analog structure-function assessment of the rapid stimulation of intestinal calcium absorption (transcaltachia).
    Zhou LX; Nemere I; Norman AW
    J Bone Miner Res; 1992 Apr; 7(4):457-63. PubMed ID: 1319106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3 and 1alpha,25-dihydroxy-16-ene-23-yne-20-epi-vitamin D3: analogs of 1alpha,25-dihydroxyvitamin D3 that resist metabolism through the C-24 oxidation pathway are metabolized through the C-3 epimerization pathway.
    Reddy GS; Rao DS; Siu-Caldera ML; Astecker N; Weiskopf A; Vouros P; Sasso GJ; Manchand PS; Uskokovic MR
    Arch Biochem Biophys; 2000 Nov; 383(2):197-205. PubMed ID: 11185554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the vitamin D3 analog 1 alpha, 25-dihydroxyvitamin D3-3 beta-bromoacetate on rat osteosarcoma cells: comparison with 1 alpha, 25-dihydroxyvitamin D3.
    Van Auken M; Buckley D; Ray R; Holick MF; Baran DT
    J Cell Biochem; 1996 Dec; 63(3):302-10. PubMed ID: 8913881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demonstration that 1 beta,25-dihydroxyvitamin D3 is an antagonist of the nongenomic but not genomic biological responses and biological profile of the three A-ring diastereomers of 1 alpha,25-dihydroxyvitamin D3.
    Norman AW; Bouillon R; Farach-Carson MC; Bishop JE; Zhou LX; Nemere I; Zhao J; Muralidharan KR; Okamura WH
    J Biol Chem; 1993 Sep; 268(27):20022-30. PubMed ID: 8397195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid control of transmembrane calcium influx by 1alpha,25-dihydroxyvitamin D3 and its analogues in rat osteoblast-like cells.
    Nakagawa K; Tsugawa N; Okamoto T; Kishi T; Ono T; Kubodera N; Okano T
    Biol Pharm Bull; 1999 Oct; 22(10):1058-63. PubMed ID: 10549855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-function studies of 1,25-dihydroxyvitamin D3 and the vitamin D endocrine system. 1,25-dihydroxy-pentadeuterio-previtamin D3 (as a 6-s-cis analog) stimulates nongenomic but not genomic biological responses.
    Norman AW; Okamura WH; Farach-Carson MC; Allewaert K; Branisteanu D; Nemere I; Muralidharan KR; Bouillon R
    J Biol Chem; 1993 Jul; 268(19):13811-9. PubMed ID: 8390978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 22-Oxacalcitriol: dissection of 1,25(OH)2D3 receptor-mediated and Ca2+ entry-stimulating pathways.
    Farach-Carson MC; Abe J; Nishii Y; Khoury R; Wright GC; Norman AW
    Am J Physiol; 1993 Nov; 265(5 Pt 2):F705-11. PubMed ID: 8238551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The rapid nongenomic actions of 1 alpha,25-dihydroxyvitamin D3 modulate the hormone-induced increments in osteocalcin gene transcription in osteoblast-like cells.
    Baran DT; Sorensen AM; Shalhoub V; Owen T; Stein G; Lian J
    J Cell Biochem; 1992 Oct; 50(2):124-9. PubMed ID: 1429879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonnuclear effects of the steroid hormone 1 alpha,25(OH)2-vitamin D3: analogs are able to functionally differentiate between nuclear and membrane receptors.
    Dormanen MC; Bishop JE; Hammond MW; Okamura WH; Nemere I; Norman AW
    Biochem Biophys Res Commun; 1994 May; 201(1):394-401. PubMed ID: 8198601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nongenomic activation of the calcium message system by vitamin D metabolites in osteoblast-like cells.
    Civitelli R; Kim YS; Gunsten SL; Fujimori A; Huskey M; Avioli LV; Hruska KA
    Endocrinology; 1990 Nov; 127(5):2253-62. PubMed ID: 2226314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1 Alpha,25-dihydroxyvitamin D3 rapidly increases cytosolic calcium in clonal rat osteosarcoma cells lacking the vitamin D receptor.
    Baran DT; Sorensen AM; Shalhoub V; Owen T; Oberdorf A; Stein G; Lian J
    J Bone Miner Res; 1991 Dec; 6(12):1269-75. PubMed ID: 1665280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolites and analogs of 1alpha,25-dihydroxyvitamin D(3): evaluation of actions in bone.
    Kadiyala S; Nagaba S; Takeuchi K; Yukihiro S; Qiu W; Eyes ST; Uskokovic MR; Posner GH; Reddy GS; Guggino SE
    Steroids; 2001; 66(3-5):347-55. PubMed ID: 11179743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone Gla protein messenger ribonucleic acid is regulated by both 1,25-dihydroxyvitamin D3 and 3',5'-cyclic adenosine monophosphate in rat osteosarcoma cells.
    Theofan G; Price PA
    Mol Endocrinol; 1989 Jan; 3(1):36-43. PubMed ID: 2464756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 24R,25-(OH)2 vitamin D3 inhibits 1alpha,25-(OH)2 vitamin D3 and testosterone potentiation of calcium channels in osteosarcoma cells.
    Takeuchi K; Guggino SE
    J Biol Chem; 1996 Dec; 271(52):33335-43. PubMed ID: 8969193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of aluminum on the regulation of PTH- and 1,25(OH)2D3-dependent pathways in the rat osteosarcoma cell line ROS 17/2.8.
    Lajeunesse D; Moreau R; Hobbs W; Qui W; Lafond J; Guggino SE
    J Bone Miner Res; 1998 Jun; 13(6):962-9. PubMed ID: 9626627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D metabolites modulate osteoblast activity by Ca+2 influx-independent genomic and Ca+2 influx-dependent nongenomic pathways.
    Khoury RS; Weber J; Farach-Carson MC
    J Nutr; 1995 Jun; 125(6 Suppl):1699S-1703S. PubMed ID: 7782930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
    Norman AW; Sergeev IN; Bishop JE; Okamura WH
    Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1 alpha,25(OH)2-vitamin D3 analog structure-function assessment of intestinal nuclear receptor occupancy with induction of calbindin-D28K.
    Zhou LX; Norman AW
    Endocrinology; 1995 Mar; 136(3):1145-52. PubMed ID: 7867568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.